Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 02/19/26
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026GlobeNewsWire • 02/18/26
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?Zacks Investment Research • 01/22/26
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 01/21/26
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 01/13/26
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 OutlookZacks Investment Research • 01/13/26
ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business UpdateGlobeNewsWire • 01/12/26
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026GlobeNewsWire • 01/05/26
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 12/12/25
Adma Biologics (ADMA) Up 43.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/05/25
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a BetZacks Investment Research • 11/27/25
Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 11/25/25
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 11/25/25
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving AverageZacks Investment Research • 11/25/25
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 11/12/25
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for InvestorsZacks Investment Research • 11/12/25
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to TradeZacks Investment Research • 11/11/25
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv SalesZacks Investment Research • 11/06/25
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 11/05/25